Overall rank by patents
#1,652
Across all tracked assignees
USPTO PatentsView assignee record - 249 granted patents across 26 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).
The verdict
Varian holds 249 US patents across 26 technology areas, rank #1,652 of 50,000 tracked assignees.
Varian Medical Systems International Ag has been granted 249 US utility patents between 2015 and 2024, placing Varian Medical Systems International Ag at rank #1,652 across all assignees tracked by PlainPatent. This portfolio spans 26 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.5 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a Foreign Corporation, Varian Medical Systems International Ag is one of the more focused assignees in the PatentsView dataset. By volume, Varian sits between AS America, Inc. (249 patents, rank #1,648) and Chicony Power Technology Co., Ltd. (248 patents, rank #1,656) - the closest US assignees by grant volume. The composite Innovation Score of 52.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 130 grants, compared with 119 in the 2015–2019 window, a +9% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Varian Medical Systems International Ag's 21.5 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 26 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Varian Medical Systems International Ag against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
AS America, Inc.
249 patents
Arkema Inc.
249 patents
Seven Networks, LLC
249 patents
Slack Technologies, LLC
249 patents
VARIAN MEDICAL SYSTEMS INTERNATIONAL AG
249 patents
ANTECIP BIOVENTURES II LLC
248 patents
Activision Publishing, Inc.
248 patents
Amadeus S.A.S.
248 patents
Chicony Power Technology Co., Ltd.
248 patents
What this shows Varian holds 249 patents at rank #1,652, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,652 in granted patent volume.
Other assignees with the most granted patents in Varian's primary technology class.
Varian's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
53 Top 10% higher than 90% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 11 | 4.4% |
| 2016 | 11 | 4.4% |
| 2017 | 25 | 10.0% |
| 2018 | 28 | 11.2% |
| 2019 | 44 | 17.7% |
| 2020 | 40 | 16.1% |
| 2021 | 39 | 15.7% |
| 2022 | 33 | 13.3% |
| 2023 | 13 | 5.2% |
| 2024 | 5 | 2.0% |
Top 15 of 26 technology areas
Overall rank by patents
#1,652
Across all tracked assignees
52.8 out of 100
How to use this portfolio
Varian's 249 grants land it in the top 10% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.